Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation.
about
Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.Label-free LC-MS/MS shotgun proteomics to investigate the anti-inflammatory effect of rCC16.CREBBP mutation in human cutaneous squamous cell carcinoma.The Role of Human Papillomaviruses and Polyomaviruses in BRAF-Inhibitor Induced Cutaneous Squamous Cell Carcinoma and Benign Squamoproliferative Lesions
P2860
Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel CARD11 Mutations in Huma ...... to Aberrant NF-κB Regulation.
@ast
Novel CARD11 Mutations in Huma ...... to Aberrant NF-κB Regulation.
@en
type
label
Novel CARD11 Mutations in Huma ...... to Aberrant NF-κB Regulation.
@ast
Novel CARD11 Mutations in Huma ...... to Aberrant NF-κB Regulation.
@en
prefLabel
Novel CARD11 Mutations in Huma ...... to Aberrant NF-κB Regulation.
@ast
Novel CARD11 Mutations in Huma ...... to Aberrant NF-κB Regulation.
@en
P2093
P2860
P50
P1476
Novel CARD11 Mutations in Huma ...... to Aberrant NF-κB Regulation.
@en
P2093
Andrew P South
Angela T McHugh
Charlotte M Proby
Dylan J Xue
Irene M Leigh
Karin J Purdie
Michelle Dimon
Stephen A Watt
P2860
P304
P356
10.1016/J.AJPATH.2015.05.018
P407
P577
2015-07-23T00:00:00Z